Cargando…
Metformin improves the weight reduction effect of mazindol in prediabetic obese Mexican subjects
Abstract. Objective: Obesity is the strongest risk factor for type 2 diabetes (T2D). We aimed to explore 7% weight reduction rates of mazindol alone or combined with metformin in non-diabetic obese Mexican subjects who had additional risk factors for T2D. Materials and methods: In this randomized do...
Autores principales: | Arguelles-Tello, Federico Alberto, Kammar-García, Ashuin, Trejo-Jasso, Cristian Adolfo, Huerta-Cruz, Juan Carlos, Barranco-Garduño, Lina Marcela, Rocha-González, Héctor Isaac, Reyes-García, Juan Gerardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341243/ https://www.ncbi.nlm.nih.gov/pubmed/35770520 http://dx.doi.org/10.5414/CP204180 |
Ejemplares similares
-
Combined First Month Body Weight Loss and Development of Tolerance as Predictors of 6-Month Efficacy of Mazindol in Mild and Moderate Obese Subjects
por: Huerta-Cruz, Juan Carlos, et al.
Publicado: (2022) -
Three- and six-month efficacy and safety of phentermine in a Mexican obese population
por: Márquez-Cruz, Maribel, et al.
Publicado: (2021) -
Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months
por: Rocha-González, Héctor Isaac, et al.
Publicado: (2021) -
Estimation of vaccination coverage and associated factors in older Mexican adults
por: García-Hernández, Héctor, et al.
Publicado: (2023) -
Association of loneliness and social isolation with all-cause mortality among older Mexican adults in the Mexican health and aging study: a retrospective observational study
por: Kammar-García, Ashuin, et al.
Publicado: (2023)